Author: Jablonský Tomáš
Institution: Catholic University, Ružomberok
Author: Okálová Oľga
Institution: Catholic University, Ružomberok
Author: Petra Nettleship
Institution: United Kingdom
Author: Utku Uçay
Institution: King’s College, London
Year of publication: 2018
Source: Show
Pages: 17-27
DOI Address:
PDF: tner/201802/tner20180201.pdf

Fetal alcohol spectrum disorder is an overarching term that describes the extent of effects of prenatal alcohol exposure. It includes the range of neurodevelopmental findings and other medical findings specific for FAS. Measurability of characteristics depends on several factors, such as diagnostic instruments, multidisciplinary focus, etc. The objective of the contribution is to provide the primary early care givers with recommendations for FASD screening. It involves suggestions that deal with recognition, protection and intervention of children with FASD in the most elaborate and unbiased manner. Results of the study offer selective intention of screening in preschool-aged children. The research was conducted with 173 children aged from 3 to 7 years. The authors used their own concept of selected domains indicating the occurrence of impairments in FASD domains. Specific quantitative and qualitative research methods were assigned to them. The impairments relate to anthropometric deviations determining early occurrence of FASD. The authors have selected the domain of basic anthropometry: head circumference, height and weight and philtrum and the obtained results from domains: auditory processing, selected cognitive components, motor system, speech and sensory processing. Conclusions define basic criteria for FASD screening in general population and basic algorithm of distribution of recognized child in a system of early care in the SR. They rely on the fact that there is urgent demand in Slovakia to involve participants in active FASD care.


  • Norman, A.L., Crocker, N., Mattson, S.N., Riley, E.P. (2012). Neuroimaging and fetal alcohol spectrum disorders. Center for Behavioral Teratology, Department of Psychology, San Diego State University, San Diego, California, ev Disabil Res Rev. PMC.
  • Archibald, S.L., Fennema-Notestine, C., Gamst, A., et al. (2001). Brain dysmorphology in individuals with severe prenatal alcohol exposure. Dev Med Child Neurol. 43: 148 – 154.
  • Astley, S.J. (2004). Diagnostic Guide for FASD. Diagnostic Guide for Fetal Alcohol Spectrum Disorders: The 4-Digit Diagnostic Code. Third Edition.
  • Bhatara, V.S., Lovrein, F., Kirkeby, J., et al. (2002). Brain function in fetal alcohol syndrome assessed by single photon emission computed tomography. S D J Med. 55: 59 – 62.
  • Bookstein, F.L., Connor, P.D., Huggins, J.E., et al. (2007). Many infants prenatally exposed to high levels of alcohol show one particular anomaly of the corpus callosum. Alcohol Clin Exp Res. 31: 868 – 879.
  • Breiner, P., Nulman, I., Koren, G. (2013). Identifying the neurobehavioral phenotype of fetal alcohol spectrum disorder in young children. J Popul Ther Clin Pharmacol. 20(3): e334 – 9.
  • Clarren, S.K., Smith, D.W. (1978). The fetal alcohol syndrome. N Engl J Med. 298: 1063 – 1067.
  • Clarren, S.K. (1986). Neuropathology in fetal alcohol syndrome. In: West JR, editor. Alcohol and brain development. New York: Oxford University Press; 158 – 166.
  • Coulter, C.L., Leech, R.W., Schaefer, G.B., et al. (1993). Midline cerebral dysgenesis, dysfunction of the hypothalamic-pituitary axis, and fetal alcohol effects. Arch Neurol. 50: 771 – 775.
  • Gerbova, M. (2017). Cognitive screening tools. Internal methodical material.
  • Gibbard, B. (2009). Extent and impact on child development. In E. Jonsson, L. Dennett, G. Littlejohn (eds). Fetal Alcohol Spectrum Disorder (FASD): Across the lifespan. Alberta, Canada: Institute of Health Economics.
  • Hanlon-Dearman, A., Green, C.R., Andrew, G., LeBlanc, N., Cook, J.L. (2015). Anticipatory guidance for children and adolescents with Fetal Alcohol Spectrum Disorder (FASD): practice points for primary health care providers. Journal of Population Therapeutics and Clinical Pharmacology, 22(1): 27 – 56.
  • Chasnoff, I. (2011). The Mystery of Risk: Drugs, Alcohol, Pregnancy, and the Vulnerable Children. Hardcover: 279 pages; Publisher: NTI Upstream. 1 edition. Chovancova, D. (2007). Neonatal screening in Slovakia. Pediatr. Prax. 1: 13 – 16.
  • Johnson, V.P., Swayze, V.W., Sato, Y., et al. (1996). Fetal alcohol syndrome: craniofacial and central nervous system manifestations. Am J Med Gen. 61: 329 – 339.
  • Jones, K.L., Smith, D.W. (1973). Recognition of the fetal alcohol syndrome in early infancy. Lancet. 2: 999 – 1001.
  • Lange, S., Rovet, J., Rehm, J., Popova S. (2017). Neurodevelopmental profile of Fetal Alcohol Spectrum Disorder: A systematic review. BMC Psychol. Jun 23; 5(1): 22. doi: 10.1186/s40359–017–0191–2.
  • Lebel, C., Rasmussen, C., Wyper, K., et al. (2008). Brain diffusion abnormalities in children with fetal alcohol spectrum disorder. Alcohol Clin Exp Res. 32: 1732 – 1740.
  • LeFrance, M.A., McLachlan, K., Nash, K., Andrew, G., Loock, C., Oberlander, T.F., et al. (2014). Evaluation of the Neurobehavioral Screening Tool in children with fetal alcohol spectrum disorders (FASD). J Popul Ther Clin Pharmacol. 21(2): e197 – 210.
  • Mattson, S.N., Riley, E.P. (1998). A review of the neurobehavioral deficits in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol Clin Exp Res. 22: 279 – 294.
  • Ministry of Health (2015). Taking Action on Fetal Alcohol Spectrum Disorder (FASD): A discussion document. Wellington: Ministry of Health. Published in December 2015 by the Ministry of Health PO Box 5013, Wellington 6145, New Zealand, ISBN 978 – 0-947491 – 52 – 9 (online) HP 6316
  • Riikonen, R.S., Nokelainen, P., Valkonen, K., et al. (2005). Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: a study with nor-β-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry. Biol Psychiatry. 57: 1565 – 1572.
  • Riikonen, R.S., Salonen, I., Partanen, K., et al. (1999). Brain perfusion SPECT and MRI in foetal alcohol syndrome. Dev Med Child Neurol. 41: 652 – 659.
  • Streissguth, A.P., Barr, H.M., Sampson, P.D., et al. (1986). Attention, distraction and reaction time at age 7 years and prenatal alcohol exposure. Neurobehav Toxicol Teratol. 8: 717 – 725.
  • Swayze, V.W., Johnson, V.P., Hanson, J.W., et al. (1997). Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics, 99: 232 – 240.

Wiadomość do:



© 2017 Adam Marszałek Publishing House. All rights reserved.

Projekt i wykonanie Pollyart